ERIKA KELLY

Allopathic & Osteopathic Physicians|Internal Medicine RUSSELL SPRINGS, KY NPI 1679934558

General Payments — all program years on this page

$540.14

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $196.48 across 12 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $196.4812

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $60.304
ABBVIE INC. $51.413
Lilly USA, LLC $32.722
Seqirus USA Inc $20.831
Exact Sciences Corporation $16.021
Novo Nordisk AS $15.201

By program year

Program yearAmountRecords
2019 $11.971
2022 $139.959
2023 $191.7412
2024 $196.4812

Records — PY2024 (12)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096743467 Novo Nordisk Inc $15.20 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104050094 ABBVIE INC. $19.10 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104050096 ABBVIE INC. $15.35 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104050098 ABBVIE INC. $16.96 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104306806 AstraZeneca Pharmaceuticals LP $14.91 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104498992 AstraZeneca Pharmaceuticals LP $13.63 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104718307 AstraZeneca Pharmaceuticals LP $18.55 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105718788 AstraZeneca Pharmaceuticals LP $13.21 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114730398 Exact Sciences Corporation $16.02 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125632842 Seqirus USA Inc $20.83 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134968563 Lilly USA, LLC $14.98 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134974167 Lilly USA, LLC $17.74 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.